HDSN

Hudson is a commodity story dressed as a specialty business. Refrigerant sales are 'a significant majority' of revenue, and the 10-K is blunt that results 'could be materially and adversely affected by changes in commodity prices' driven by 'weather, seasonality, the availability and adequacy of supply' — all beyond its control. The numbers show exactly that cycle unwinding: net income has fallen every year from the $104M FY2022 refrigerant-price spike to $52.2M, $24.4M, and now $16.7M (-31.7% YoY), even as revenue ticked up 4%. Gross margin compressed to 25.2% (gross profit -5.5%) and operating income fell -36.7%, so the pressure is price/mix, not volume. This is mid-cycle-decline earnings being valued at 16x — reasonable, not a bargain, on a trajectory that is still pointed down.

What keeps this a hold rather than a sell is the balance sheet and the asset backing. Liabilities/equity is just 0.31x, current assets ($211M) cover current liabilities ($64.6M) more than 3x, and equity of $243M is roughly $5.72/share — so at $5.99 the stock trades near book, with retained earnings up 12.4%. Management is leaning into that value, more than doubling buybacks to $20M (shrinking the count 3.5%). The structural kicker is the HFC phasedown: as one of the largest US reclaimers restoring refrigerants to AHRI standard, Hudson's reclaim economics should improve as virgin HFC supply is squeezed over time.